Concepedia

Publication | Open Access

Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG)

DOIFull Paper Access

36

Citations

18

References

2018

Year

Germán Reyes-Botero, Stéphanie Cartalat‐Carel, Olivier Chinot, Maryline Barrié, Luc Taillandier, Patrick Beauchesne, Isabelle Catry‐Thomas, Jérôme Barrière, Jean‐Sébastien Guillamo, Michel Fabbro,
The Oncologist

Abstract

This study suggests that TMZ + Bev treatment is active in elderly patients with GBM with low KPS and has an acceptable tolerance level.

References

YearCitations

Page 1